tiprankstipranks
Trending News
More News >
Beauty Kadan Holdings Co. Ltd. (JP:3041)
:3041
Japanese Market
Advertisement

Beauty Kadan Holdings Co. Ltd. (3041) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3041

Beauty Kadan Holdings Co. Ltd.

(3041)

Rating:51Neutral
Price Target:
¥458.00
▲(0.22% Upside)
The overall stock score is primarily driven by financial performance concerns, particularly profitability and leverage issues. Technical analysis indicates bearish momentum, and valuation metrics highlight profitability challenges. Revenue growth offers a positive note, but strategic improvements are necessary for a better outlook.

Beauty Kadan Holdings Co. Ltd. (3041) vs. iShares MSCI Japan ETF (EWJ)

Beauty Kadan Holdings Co. Ltd. Business Overview & Revenue Model

Company DescriptionBeauty Kadan Holdings Co. Ltd. (3041) operates within the beauty and personal care industry, offering a range of products and services aimed at enhancing personal aesthetics and well-being. The company is involved in the development, manufacturing, and distribution of beauty products, as well as providing beauty-related services. Its core offerings include cosmetics, skincare products, and beauty treatment services, catering to a diverse clientele interested in enhancing their appearance and self-care routines.
How the Company Makes MoneyBeauty Kadan Holdings Co. Ltd. generates revenue through the sale of its proprietary beauty and skincare products, which are distributed through various retail and online channels. The company also earns income from its beauty treatment services, which are provided in specialized salons and through partnerships with other beauty service providers. Key revenue streams include direct product sales, service fees from beauty treatments, and possibly licensing agreements for exclusive products. Strategic partnerships with retailers and beauty professionals, along with marketing and branding efforts, significantly contribute to the company's earnings by expanding its market reach and customer base.

Beauty Kadan Holdings Co. Ltd. Financial Statement Overview

Summary
Beauty Kadan Holdings shows consistent revenue growth but faces challenges with profitability and cash flow. The high debt-to-equity ratio and negative net income highlight financial risk, while stable gross profit margins are a positive aspect.
Income Statement
65
Positive
Beauty Kadan Holdings has shown a consistent increase in total revenue over the years, with a noticeable growth from 5,858M in 2022 to 7,306M in the TTM period of 2024. However, the company reported a negative net income for the TTM, indicating profitability challenges. The gross profit margin is stable, but the declining EBIT and negative net profit margin highlight operational inefficiencies.
Balance Sheet
58
Neutral
The company's balance sheet shows a high debt-to-equity ratio, indicating significant leverage, which poses financial risk. The equity ratio is moderate, but the return on equity has been impacted by negative income in the TTM period. The company's assets have grown, yet the equity base has not strengthened proportionately.
Cash Flow
50
Neutral
Beauty Kadan Holdings' cash flow analysis reveals volatility, with zero operating cash flow in the TTM period, indicating cash management concerns. Historical free cash flow shows irregular growth, and the company's ability to convert operating income into cash has weakened, as seen in the low operating cash flow to net income ratio.
BreakdownTTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income Statement
Total Revenue7.51B6.98B6.41B5.86B5.35B5.34B
Gross Profit964.56M994.39M941.02M902.62M785.16M753.61M
EBITDA87.27M145.53M179.44M178.31M161.54M-123.06M
Net Income-24.73M28.54M88.82M86.32M81.78M-222.94M
Balance Sheet
Total Assets2.65B2.72B2.46B2.44B2.44B2.20B
Cash, Cash Equivalents and Short-Term Investments766.59M1.07B954.90M950.45M976.36M778.92M
Total Debt1.40B1.48B1.31B1.31B1.47B1.32B
Total Liabilities2.11B2.17B1.92B1.91B2.01B1.85B
Stockholders Equity535.80M544.11M545.46M488.94M402.62M320.82M
Cash Flow
Free Cash Flow0.0025.39M91.42M143.87M44.93M-82.83M
Operating Cash Flow0.0098.46M105.99M157.78M57.82M1.73M
Investing Cash Flow0.00-72.39M-31.45M-14.99M-5.63M-78.90M
Financing Cash Flow0.0090.40M-70.09M-168.69M145.25M230.71M

Beauty Kadan Holdings Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price457.00
Price Trends
50DMA
456.50
Positive
100DMA
478.42
Negative
200DMA
422.12
Positive
Market Momentum
MACD
-1.83
Negative
RSI
46.37
Neutral
STOCH
45.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3041, the sentiment is Negative. The current price of 457 is below the 20-day moving average (MA) of 457.80, above the 50-day MA of 456.50, and above the 200-day MA of 422.12, indicating a neutral trend. The MACD of -1.83 indicates Negative momentum. The RSI at 46.37 is Neutral, neither overbought nor oversold. The STOCH value of 45.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3041.

Beauty Kadan Holdings Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥2.35B10.88
5.26%25.64%
61
Neutral
$17.92B12.81-0.76%2.98%1.30%-14.28%
60
Neutral
¥3.01B23.90
-3.96%-73.55%
56
Neutral
¥2.19B7.99
3.54%-2.89%-144.95%
51
Neutral
¥1.85B43.39
1.97%8.87%48.11%
44
Neutral
¥1.52B
-7.04%83.17%
42
Neutral
¥2.14B
-18.74%-1062.47%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3041
Beauty Kadan Holdings Co. Ltd.
457.00
75.98
19.94%
JP:2196
ESCRIT Inc.
224.00
-17.00
-7.05%
JP:4679
TAYA Co.,Ltd.
253.00
-104.00
-29.13%
JP:6186
ICHIKURA Co., Ltd.
395.00
-130.60
-24.85%
JP:7372
Decollte Holdings Corporation
455.00
141.00
44.90%
JP:7578
Nichiryoku Co., Ltd.
123.00
-25.00
-16.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 02, 2025